Why one U.S. biotech firm is listing in Hong Kong before Wall Street
HONG KONG, CHINA: Hong Kong has emerged as a major biotech fundraising hub, attracting dozens of Chinese biotech firms to list in the city. Cheng Xin | Getty Images News | Getty Images For years, Chinese companies such as Alibaba and Baidu headed to the U.S. to list their shares, citing its deeper capital markets…
